CYP3A4 HUMANIZED MOUSE; A MODEL TO STUDY CYP3A4-MEDIATED DRUG-DRUG INTERACTION POTENTIAL

被引：0
|
作者：
Rose, Anne [1 ]
Xu, Carrie [1 ]
Johnghar, Susan [1 ]
Behnia, Kamelia [1 ]
机构：
[1] Bristol Myers Squibb Co, New York, NY 10154 USA
来源：
DRUG METABOLISM REVIEWS | 2012年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：76 / 77
页数：2
相关论文
共 50 条
  • [21] QUANTITATIVE PREDICTION OF CYP3A4 AND CYP3A5-MEDIATED DRUG DRUG INTERACTIONS
    Guo, Yingying
    Lucksiri, Aroonrut
    Dickinson, Gemma
    Vuppalanchi, Raj
    Hilligoss, Janna
    Huang, Shiew-Mei
    Hall, Stephen
    DRUG METABOLISM AND PHARMACOKINETICS, 2020, 35 (01) : S43 - S44
  • [22] CYP3A mediated drug-drug interactions: Contribution of CYP 3A4 and CYP 3A5
    Patki, KC
    von Moltke, LL
    Greenblatt, DJ
    JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (09): : 1057 - 1057
  • [23] Metabolic Pathway of Icotinib In Vitro: The Differential Roles of CYP3A4, CYP3A5, and CYP1A2 on Potential Pharmacokinetic Drug-Drug Interaction
    Zhang, TianHong
    Zhang, KeRong
    Ma, Li
    Li, Zheng
    Wang, Juan
    Zhang, YunXia
    Lu, Chuang
    Zhu, Mingshe
    Zhuang, XiaoMei
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 107 (04) : 979 - 983
  • [24] Fluorescent probes for rapid screening of potential drug-drug interactions at the CYP3A4 level
    Chougnet, Antoinette
    Grinkova, Yelena
    Ricard, David
    Sligar, Stephen
    Woggon, Wolf-D.
    CHEMMEDCHEM, 2007, 2 (05) : 717 - 724
  • [25] A Physiologically Based Pharmacokinetic and Pharmacodynamic Model of the CYP3A4 Substrate Felodipine for Drug-Drug Interaction Modeling
    Fuhr, Laura Maria
    Marok, Fatima Zahra
    Mees, Maximilian
    Mahfoud, Felix
    Selzer, Dominik
    Lehr, Thorsten
    PHARMACEUTICS, 2022, 14 (07)
  • [26] Effects of drug-drug interactions and CYP3A4 variants on alectinib metabolism
    Ya-nan Liu
    Jie Chen
    Jing Wang
    Qingqing Li
    Guo-xin Hu
    Jian-ping Cai
    Guanyang Lin
    Ren-ai Xu
    Archives of Toxicology, 2023, 97 : 2133 - 2142
  • [27] Effects of drug-drug interactions and CYP3A4 variants on alectinib metabolism
    Liu, Ya-nan
    Chen, Jie
    Wang, Jing
    Li, Qingqing
    Hu, Guo-xin
    Cai, Jian-ping
    Lin, Guanyang
    Xu, Ren-ai
    ARCHIVES OF TOXICOLOGY, 2023, 97 (08) : 2133 - 2142
  • [28] Case of Imatinib Susceptibility to CYP3A4-Mediated Drug-Drug Interactions in a Patient With Gastrointestinal Stromal Tumor
    Fujimiya, Tatsuhiro
    Sugita, Hideki
    Kin, Masaoki
    Funakoshi, Haruki
    Kubota, Yutaro
    Tsunoda, Takuya
    AMERICAN JOURNAL OF THERAPEUTICS, 2024, 31 (01) : e66 - e69
  • [29] Quantitative prediction of CYP3A4 drug-drug interactions: Extending the strategy
    Galetin, A
    Hallifax, D
    Ito, K
    Houston, JB
    DRUG METABOLISM REVIEWS, 2003, 35 : 62 - 62
  • [30] Effect of methylprednisolone on CYP3A4-mediated drug metabolism in vivo
    Villikka, K
    Varis, T
    Backman, JT
    Neuvonen, PJ
    Kivistö, KT
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 57 (6-7) : 457 - 460
12345